Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus

BACKGROUND: After the discovery that cell-free fetal DNA (cffDNA) is circulating in the maternal plasma of pregnant women, non-invasive prenatal diagnosis for fetal RhD in maternal plasma in RhD negative women at risk for haemolytic disease of the newborn (HDN) was clinically established and used by...

Descripción completa

Detalles Bibliográficos
Autores principales: Papasavva, Thessalia, Martin, Pete, Legler, Tobias J., Liasides, Marios, Anastasiou, George, Christofides, Agathoklis, Christodoulou, Tasos, Demetriou, Sotos, Kerimis, Prokopis, Kontos, Charis, Leontiades, George, Papapetrou, Demetris, Patroclos, Telis, Phylaktou, Marios, Zottis, Nikos, Karitzie, Eleni, Pavlou, Eleni, Kountouris, Petros, Veldhuisen, Barbera, van der Schoot, Ellen, Kleanthous, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818414/
https://www.ncbi.nlm.nih.gov/pubmed/27036548
http://dx.doi.org/10.1186/s13104-016-2002-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818414/
https://www.ncbi.nlm.nih.gov/pubmed/27036548
http://dx.doi.org/10.1186/s13104-016-2002-x

Ejemplares similares